Lobbying Information
Subject Matters
- Consumer Issues
- Health
- Industry
- Intellectual Property
- International Trade
- Science and Technology
Subject Matter Details
Policies or Program
- Federal public drug plans, specifically the Non-Insured Health Benefits Program (Health Canada), with respect to decisions and policies that impact reimbursement of therapeutic products for plan beneficiaries
- Food and Drugs Act, specifically with respect to the approval, regulation and life-cycle management of therapeutic products
- Health Canada Health Products & Food Regulatory Modernization
- Health care system policies or programs with respect to pharmaceuticals
- Patent Act as it relates to the regulation of intellectual property for therapeutic products
- Patent Act with respect to Canada's Access to Medicines Regime (ss. 21.01-21.09)
- Patented Medicine Prices Review Board with respect to regulations of reporting obligations of patentees
- Patented Medicine Prices Review Board with respect to the regulation of pricing of patented drug products
- Policies or programs with respect to Federal Public Drug Benefit Programs
- Proposed and potential policies with respect to current or potential regulation of cross-border trade in pharmaceuticals, including the Export Control List
- Science and Technology Strategy led by Industry Canada, particularly with respect to the life sciences priority under the S&T Strategy
Regulation
- Food and Drug Regulations specifically with respect to approval, regulation and life-cycle management of therapeutic products
- Food and Drug Regulations with respect to Data Protection under. C.08.004
- Patent Act regulations as they relate to the regulation of intellectual property for therapeutic products and the Patented Medicines (Notice of Compliance) Regulations
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
2920 Matheson Blvd. East
Mississauga, ON L4W 5R6
Canada
Telephone number:
905-282-5583
Client representative
Heather McDonald, Head, Market Access and Government Affairs
Parent Company Information
Coalition Members Information
BAYER INC. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of BAYER INC. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
BAYER INC. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
CARL BALTARE
|
Public offices held
Business address:
50 O'CONNOR ST.
SUITE 901
OTTAWA, ON K1P 6L2
Canada
Telephone number:
613-783-3438
Fax number:
613-782-2426
Consultant Firm and Address
Firm:
GLOBAL PUBLIC AFFAIRS
Address:
50 O'CONNOR ST. SUITE 901
OTTAWA, ON K1P 6L2
Canada
Telephone number:
613-783-3438
Fax number:
613-782-2426
